Format

Send to

Choose Destination
Med Sci (Paris). 2019 Dec;35(12):1160-1162. doi: 10.1051/medsci/2019220. Epub 2020 Jan 6.

[EMABling®, a technology boosting the effector function of monoclonal antibodies: history and clinical applications twenty years after the discovery].

[Article in French]

Author information

1
LFB Biotechnologies, Lille, France.
PMID:
31903931
DOI:
10.1051/medsci/2019220

Supplemental Content

Full text links

Icon for EDP Sciences
Loading ...
Support Center